A major investment company is putting 1 million Canadian dollars ($780,000) on the table for aspiring cannabis entrepreneurs in Canada. Canopy Rivers Corp.'s program is open to entrepreneurs looking to access Health Canada’s proposed new licenses for...
Matt Lamers
Matt Lamers's Latest Posts
Micro-cultivation canopy limit clarified for Canadian cannabis growers
Proprietors who obtain micro-cultivation licenses in Canada under a new proposal won’t be able to circumvent the canopy limit by growing cannabis on vertically arranged spaces. The proposed limit of 200 square meters for micro-cultivation licensees would be based on...
Colombian marijuana companies seek first listings on Canadian exchange
As interest in Latin America’s medical marijuana industry grows, a major stock exchange in Canada could soon see the first listings from companies with their core operations in Colombia. Khiron Life Sciences CEO Alvaro F. Torres told Marijuana Business Daily the...
What Canada’s top CEOs say about cannabis ‘commoditization’
While a shortage of marijuana is expected to precede any glut by a number of years, the potential for cannabis commoditization is already a consideration for many licensed cultivators in Canada. Greg Engel, CEO of New Brunswick-based Organigram, said commoditization,...
Fearing cannibalization, beer companies ask Canada for higher cannabis taxes
Canada’s beer industry is expressing concern that the recreational marijuana market is going to cut into its profits, and it wants the government to raise the proposed tax to level the playing field.
Thailand set to unveil medical cannabis law
A draft law to greatly expand medical cannabis regulations in Thailand is expected to be unveiled this week, a move that executives say will open the door to potentially millions of dollars in investments. In the works since last year, the draft narcotics code will...
Canopy seeks to become first marijuana producer traded on New York Stock Exchange
Canada’s market leader in medical marijuana has applied to trade its shares on the New York Stock Exchange, a move that would make it the first cannabis-producing company to list on the world’s largest stock market.
Smiths Falls, Ontario-based Canopy Growth said in a news release it expects its shares to begin trading on the NYSE “before the end of May” under the symbol CGC.
Cultivator to sell cannabis at production facility – a first in Canada
Canopy Growth, a licensed producer in Newfoundland, has received permission to sell marijuana to consumers at its cultivation facility, a process known as farm-gate. It’s an industry-first in Canada that executives hope will catch on nationwide.
Canopy Growth announced this week that consumers will be able to buy cannabis products at a Tweed store on its production site.
So far no other province has indicated it will allow farm-gate sales.
Provincial Preview: Saskatchewan is ‘ground zero for the green rush’
The Land of Seed and Honey is throwing its doors wide open to the marijuana industry.
Saskatchewan’s model is being hailed as the best in Canada in terms of creating opportunities for entrepreneurs in areas ranging from cultivation and retail to cannabis-related tourism and security.
How India can become a global cannabis leader: Q&A with Bombay Hemp’s Avnish Pandya
India’s medical marijuana industry will blossom if companies use science to convince regulators that MMJ is an effective medicine. That's the view of the country’s only licensed medical cannabis cultivator. Avnish Pandya, co-founder of Bombay Hemp Co., said the best...
Report: Uruguay is home to nearly 35,000 authorized rec cannabis users
The number of people authorized to access recreational marijuana in Uruguay is closing in on 35,000, according to a report by the Institute of Regulation and Control of Cannabis. However, the Uruguayan regulatory agency's study notes that the number of people...
McLellan calls on Canadian Senate to avoid ‘undue partisanship’ to get around rec cannabis delay
The former chair of Canada's federal task force on cannabis legalization is calling on senators to avoid “undue partisan activity” as the bill faces the potential of a delay over contentious amendments that are under consideration. The Senate has every right to...













